Arthur Ozeki - 12 Mar 2026 Form 4 Insider Report for REINSURANCE GROUP OF AMERICA INC (RGA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
16 Mar 2026, 21:12:16 UTC
Prior SEC filing
20 Jan 2026
Next SEC filing
27 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ My Chi To, by Power of Attorney

Key filing fact

Arthur Ozeki filed Form 4 for REINSURANCE GROUP OF AMERICA INC (RGA) on 16 Mar 2026.

Key facts

  • This page summarizes Arthur Ozeki's Form 4 filing for REINSURANCE GROUP OF AMERICA INC (RGA).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 16 Mar 2026, 21:12.

Change

  • Previous filing in this sequence was filed on 20 Jan 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002005023 Primary reporting owner

Ozeki Arthur

Relationship
EVP, Head of Asia Pacific
Address
16600 SWINGLEY RIDGE ROAD, CHESTERFIELD
Signature
/s/ My Chi To, by Power of Attorney
Signature date
16 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RGA transaction

Common stock

Options Exercise

Transaction value
Shares
+2,689
Change %
+26%
Price
$205.00*
Shares after
13,036
Date
12 Mar 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RGA transaction Derivative

Performance Contingent Shares 2026

Options Exercise

Transaction value
Shares
-2,689
Change %
-100%
Price
$0.000000*
Shares after
0
Date
12 Mar 2026
Ownership
Direct
Underlying class
Common stock
Underlying amount
2,689
Exercise price
$0.000000
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Acquired pursuant to award of Performance Contingent Stock granted on March 9, 2023.

Footnote F2

Each Performance Contingent Stock unit represents the right to receive one (1) share of Issuer's Common Stock.

Footnote F3

Expiration date is not applicable for this transaction.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .